Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831

Clinical trial NCT04480333 · UNKNOWN

Trial details

NCT number: NCT04480333
Sponsor: Biomed Industries, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Covid19 Corona Virus Infection Severe Acute Respiratory Syndrome Severe Acute Respiratory Infection Severe Acute Respiratory Syndrome (SARS) Pneumonia Severe Acute Respiratory Syndrome of Upper Respiratory Tract Neurodegeneration Neuroinflammatory Response

Start date: 2020-09-15
Primary completion: 2020-12-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.